Patent Assignment
Reel/Frame 031019/0937
Assignment of Assignor's Interest
Recorded: 2013-08-15
Pages: 11
Assignor
ISTA PHARMACEUTICALS, LLC
Executed: 2013-07-26
Assignee
BAUSCH & LOMB PHARMA HOLDINGS CORP.
ONE BAUSCH & LOMB PLACE, ROCHESTER, NEW YORK, 14604
Covered Properties
(18)
A Method for Accelerating Clearance of Hemorrhagic Blood from the Vireous Humor with Hyaluronidase
Patent:
5,866,120 →
Application:
08/561,636 →
Methods and Apparatus for Accelerated Orthokeratology
Patent:
6,161,544 →
Application:
09/014,955 →
Method for Accelerating Clearance of Hemorrhagic Blood from the Vitreous Body with Hyaluronidase
Patent:
6,039,943 →
Application:
09/139,282 →
Use of Hyaluronidase in the Manufacture of an Ophthalmic Preparation for Liquefying Vitreous Humor in the Treatment of Eye Disorders
Hyaluronidase Preparation for Ophthalmic Administration and Enzymatic Methods for Accelerating Clearance of Hemorrhagic Blood from the Vireous Body of the Eye
Compositions and Methods for the Induction of Retinal Detachments
Hyaluronidase Preparation for Ophtalmic Administration and Enzymatic Methods for Accelerating Clearance of Hemorrhagic Blood from the Vitreous Body of the Eye
Use of Hyaluronidase in the Manufacture of an Ophthalmic Preparation for Liquefying Vitreous Humor in the Treatment of Eye Disorders
Ophthalmic Formulations and Uses Thereof
Bromfenac Ophthalmic Formulations and Methods of Use
Application:
11/755,662 →
Publication:
US 2007/0287749
Ophthalmic NSAIDS as Adjuvants
Application:
12/867,470 →
Publication:
US 2011/0054031
Ophthalmic Formulations and Uses Thereof
Bepotastine Compositions
Application:
13/462,375 →
Publication:
US 2012/0225905
Bepotastine Compositions
Bepotastine Compositions
Application:
13/505,426 →
Publication:
US 2013/0046240
Bepotastine Compositions
Application:
13/505,438 →
Publication:
US 2012/0323178
Bromfenac Bioavailability
Aqueous Liquid Composition Containing 2-Amino-3-(4-Bromobenzoyl)Phenylacetic Acid
Application:
61/727,940 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Release of Security Interest
Jun 8, 2012
From: SPROUT CAPITAL IX, L.P.; SPROUT ENTREPRENEURS' FUND, L.P.; DONALDSON, LUFKIN & JENRETTE SECURITIES CORPORATION, AS NOMINEE FOR DLJ FIRST ESC, L.P., EMA 2001 PLAN, L.P., CSFB 2001 INVESTORS, L.P., CREDIT SUISSE FIRST BOSTON PRIVATE EQUITY, INC., DOCKLANDS 2001 PLAN, L.P., PARADEPLATZ 2001 PLAN, L.P.; INVESTOR GROWTH CAPITAL LIMITED
To: ISTA PHARMACEUTICALS, INC.
Reel/Frame 028347/0088 →
Security Agreement
Jun 29, 2012
From: ISTA PHARMACEUTICALS, INC.
To: CITIBANK, N.A.
Reel/Frame 028488/0019 →
Assignment of Assignor's Interest
Nov 8, 2012
From: PADILLA, ANGEL; BAKLAYAN, GEORGE
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 029265/0408 →
Assignment of Assignor's Interest
Dec 19, 2012
From: PADILLA, ANGELIQUEO E.; BAKLAYAN, GEORGE A.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 029497/0542 →
Release of Security Interest
Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
Security Agreement
Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
Security Agreement
Nov 1, 2013
From: BAUSCH & LOMB PHARMA HOLDINGS CORP.
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031533/0859 →
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Assignment of Assignor's Interest
Nov 2, 2016
From: BAUSCH & LOMB INCORPORATED
To: BAUSCH & LOMB PHARMA HOLDINGS CORP.
Reel/Frame 040195/0629 →
Security Interest
Jul 19, 2017
From: BAUSCH & LOMB PHARMA HOLDINGS CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043046/0030 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Merger
Dec 4, 2019
From: RHC HOLDINGS, INC.; SIGHT SAVERS, INC.; B&L FINANCIAL HOLDINGS CORP.; BAUSCH & LOMB CHINA, INC.
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 051177/0793 →
Security Interest
Jun 8, 2021
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 056811/0814 →
Security Agreement
Feb 10, 2022
From: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.; MEDICIS PHARMACEUTICAL CORPORATION
To: THE BANK OF NEW YORK MELLON
Reel/Frame 059121/0001 →
Patent Security Agreement
May 10, 2022
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK, N.A. AS COLLATERAL AGENT
Reel/Frame 059913/0548 →
Release of Security Interest in Specified Patents (Reel/Frame 045444/0299)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC
Reel/Frame 061779/0001 →
Release of Security Interest in Specified Patents (Reel/Frame 031156/0508)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061778/0446 →
Release of Security Interest in Specified Patents (Reel/Frame 031533/0859)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061778/0306 →
Release of Security Interest in Specified Patents (Reel/Frame 034749/0689)
Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
Omnibus Patent Security Release Agreement (Reel/Frame 059121/0001)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED
Reel/Frame 061873/0001 →
Omnibus Patent Security Release Agreement (Reel/Frame 043251/0932)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061872/0099 →
Omnibus Patent Security Release Agreement (Reel/Frame 045444/0634)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
Omnibus Patent Security Release Agreement (Reel/Frame 048556/0758)
Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH COMPANIES INC.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0484 →